Study of c-myb RNA Splicing in Leukemia
Author Information
Author(s): Zhou Ye, E. O'Rourke, John P. Edwards, Jeremy S. Ness, Scott A. Lewin
Primary Institution: University of New Mexico Health Sciences Center
Hypothesis
Can alternative RNA splicing of c-myb serve as a biomarker for leukemia?
Conclusion
The study found that c-myb alternative splicing is significantly elevated in leukemia samples and may correlate with patient survival.
Supporting Evidence
- Leukemia samples expressed more than 60 different c-myb splice variants.
- The polony assay detected splice variants that were not detectable by conventional methods.
- Higher levels of the 9S/10 splice variant correlated with poorer survival in patients.
Takeaway
This study looked at how a gene called c-myb changes in leukemia. It found that these changes could help doctors understand how serious the leukemia is.
Methodology
The study used a single molecule assay to analyze c-myb RNA splicing patterns in leukemia and normal cells.
Limitations
The study was conducted on a small cohort of patients, which may limit the generalizability of the findings.
Participant Demographics
Pediatric patients with precursor B-ALL.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website